• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性上皮性卵巢肿瘤的预后因素

Prognostic factors in malignant epithelial ovarian tumors.

作者信息

Sigurdsson K, Alm P, Gullberg B

出版信息

Gynecol Oncol. 1983 Jun;15(3):370-80. doi: 10.1016/0090-8258(83)90055-0.

DOI:10.1016/0090-8258(83)90055-0
PMID:6862292
Abstract

In a study of 494 patients with ovarian carcinoma all known factors that eventually influence prognosis were tested both separately and comparatively in a multivariate statistical analysis, using survival as the dependent variable. It was found that the histologic grade and the size of the residual tumor after surgery are the most important factors influencing survival. The histologic type affected prognosis only in Stage III patients with large residual tumors. The stage of tumor progression had prognostic value, although Stage IIa was found to have the same survival rate as Stage I of this disease. The state of the tumor capsules in Stage I had no prognostic effect. Ascites only affected survival in Stage III patients who had small or no residual tumor after surgery. Age was found to influence survival only in Stage III patients with small residual tumors, or no residual tumor, and in advanced Stage II cases. Continued chemotherapy seems to be of benefit in Stage III patients with small or no residual tumors following surgery.

摘要

在一项针对494例卵巢癌患者的研究中,所有最终影响预后的已知因素都在多变量统计分析中分别进行了测试,并进行了比较,将生存率作为因变量。结果发现,组织学分级和手术后残留肿瘤的大小是影响生存的最重要因素。组织学类型仅在有大残留肿瘤的III期患者中影响预后。肿瘤进展阶段具有预后价值,尽管发现IIa期与该疾病的I期生存率相同。I期肿瘤包膜状态无预后影响。腹水仅影响术后残留肿瘤小或无残留肿瘤的III期患者的生存。发现年龄仅在残留肿瘤小或无残留肿瘤的III期患者以及晚期II期病例中影响生存。对于术后残留肿瘤小或无残留肿瘤的III期患者,持续化疗似乎有益。

相似文献

1
Prognostic factors in malignant epithelial ovarian tumors.恶性上皮性卵巢肿瘤的预后因素
Gynecol Oncol. 1983 Jun;15(3):370-80. doi: 10.1016/0090-8258(83)90055-0.
2
Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.上皮巨噬细胞集落刺激因子(CSF-1)及其受体的过表达:上皮性卵巢癌的不良预后因素,与基质CSF-1的保护作用形成对比。
Clin Cancer Res. 1997 Jun;3(6):999-1007.
3
Prognostic SIGNIFICANCE of Cytoreductive Therapy of Ovarian Cancer - eastern Croatia experience.卵巢癌减瘤治疗的预后意义——克罗地亚东部的经验
Acta Clin Croat. 2019 Jun;58(2):311-320. doi: 10.20471/acc.2019.58.02.15.
4
[Assessment of prognostic factors in common ovarian tumors of varying malignancy].[不同恶性程度常见卵巢肿瘤的预后因素评估]
Magy Onkol. 2004;48(3):259-65. Epub 2004 Nov 1.
5
[Prognostic factors of epithelial ovarian cancer in young women].[年轻女性上皮性卵巢癌的预后因素]
Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):264-7.
6
[Prognostic factors for survival of ovarian epithelial cancers: apropos of 287 cases].
Gynecol Obstet Fertil. 2000 Mar;28(3):223-31.
7
The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.FIGO III期卵巢癌患者中残留病灶、FIGO亚分期、肿瘤组织学及分级的预后意义。
Gynecol Oncol. 1995 Feb;56(2):175-80. doi: 10.1006/gyno.1995.1027.
8
Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.P-糖蛋白、谷胱甘肽S-转移酶π、c-erbB-2和p53作为卵巢癌预后因素的价值。
J Clin Oncol. 1995 Jan;13(1):70-8. doi: 10.1200/JCO.1995.13.1.70.
9
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.上皮性卵巢癌国际妇产科联盟(FIGO)分期 IIA-IV 期患者残余肿瘤大小的预后价值:OVCAD 数据分析。
Int J Gynecol Cancer. 2012 Mar;22(3):380-5. doi: 10.1097/IGC.0b013e31823de6ae.
10
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.手术、化疗及大剂量放疗治疗的III期上皮性卵巢癌患者中腹膜种植及术后残留大小的预后意义。
Gynecol Oncol. 1999 Sep;74(3):400-7. doi: 10.1006/gyno.1999.5477.

引用本文的文献

1
Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma.调控上皮性卵巢癌器官特异性转移的分子机制
Cancers (Basel). 2018 Nov 15;10(11):444. doi: 10.3390/cancers10110444.
2
Ovarian cancer in endometriosis: clinical and molecular aspects.子宫内膜异位症中的卵巢癌:临床与分子层面
Minerva Ginecol. 2014 Apr;66(2):155-64.
3
Considerations in the surgical management of ovarian cancer in the elderly.老年卵巢癌的手术治疗考虑因素。
Curr Treat Options Oncol. 2013 Mar;14(1):12-21. doi: 10.1007/s11864-012-0216-2.
4
Long-term oncological outcomes of ovarian serous carcinomas with psammoma bodies: a novel insight into the molecular pathogenesis of ovarian epithelial carcinoma.具有砂粒体的卵巢浆液性癌的长期肿瘤学结局:卵巢上皮性癌分子发病机制的新见解。
Cancer Sci. 2010 Jun;101(6):1550-6. doi: 10.1111/j.1349-7006.2010.01556.x. Epub 2010 Mar 10.
5
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.82例上皮性卵巢癌患者中,集落刺激因子1的循环水平作为预后指标。
Br J Cancer. 1994 Feb;69(2):342-6. doi: 10.1038/bjc.1994.62.
6
Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies.肿瘤浸润淋巴细胞的免疫效应及其与卵巢恶性肿瘤患者生存率的关系。
J Tongji Med Univ. 1991;11(4):235-9. doi: 10.1007/BF02888158.
7
Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry. Correlation with prognostic features.通过流式细胞术和静态细胞术评估卵巢肿瘤中的增殖活性。与预后特征的相关性。
Am J Pathol. 1992 Sep;141(3):699-706.